Anti-IgE class drugs

1 result
  • xolair

    (omalizumab)
    Genentech, Inc.
    XOLAIR is indicated for adults and children aged 6 and older with moderate to severe asthma, chronic rhinosinusitis with nasal polyps, IgE-mediated food allergies, and chronic spontaneous urticaria. It is not for acute bronchospasm or emergency allergic reactions.